Cargando…

Development and validation of a prognostic score for long‐term transplant‐free survival in autoimmune hepatitis type 1

BACKGROUND: No prognostic score is currently available for long‐term survival in autoimmune hepatitis (AIH) patients. OBJECTIVE: The aim of this study was to develop and validate such a prognostic score for AIH patients at diagnosis. METHODS: The prognostic score was developed using uni‐ & multi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Biewenga, Maaike, Verhelst, Xavier P.D.M.J., Baven‐Pronk, Martine A.M.C., Putter, Hein, van den Berg, Aad P., van Nieuwkerk, Karin C.M.J., van Buuren, Henk R., Bouma, Gerd, de Boer, Ynte S., Simoen, Cedric, Colle, Isabelle, Schouten, Jeoffrey, Sermon, Filip, van Steenkiste, Christophe, van Vlierberghe, Hans, van der Meer, Adriaan J., Nevens, Frederik, van Hoek, Bart
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Hepatobiliary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8281048/ https://www.ncbi.nlm.nih.gov/pubmed/34165262 http://dx.doi.org/10.1002/ueg2.12112

Ejemplares similares

Role of age in presentation, response to therapy and outcome of autoimmune hepatitis
por: Baven-Pronk, Martine A. M. C., et al.
Publicado: (2018)

Calcineurin Inhibitors in the Treatment of Adult Autoimmune Hepatitis: A Systematic Review
por: Baven-Pronk, Martine AMC, et al.
Publicado: (2022)

Questionnaire PLD‐complaint‐specific assessment identifies need for therapy in polycystic liver disease: A multi‐centric prospective study
por: Billiet, Antoon, et al.
Publicado: (2023)

The natural course of giant paraesophageal hernia and long-term outcomes following conservative management
por: Oude Nijhuis, Renske A B, et al.
Publicado: (2020)

Can we predict the future of patients with liver cirrhosis using volumetrics?
por: Lantinga, Marten A., et al.
Publicado: (2022)

Clinical management of chronic hepatitis B: A concise overview
por: Furquim d’Almeida, Arno, et al.
Publicado: (2021)

Referral care paths for non‐alcoholic fatty liver disease—Gearing up for an ever more prevalent and severe liver disease
por: van Dijk, Anne‐Marieke, et al.
Publicado: (2021)

Neoadjuvant Treatment with Angiogenesis‐Inhibitor Dovitinib Prior to Local Therapy in Hepatocellular Carcinoma: A Phase II Study
por: Woei‐A‐Jin, F.J. Sherida H., et al.
Publicado: (2021)

International external validation of a stratification tool to identify branch‐duct intraductal papillary mucinous neoplasms at lowest risk of progression
por: Overbeek, Kasper A., et al.
Publicado: (2022)

Preoperative Imaging of Colorectal Liver Metastases After Neoadjuvant Chemotherapy: A Meta-Analysis
por: van Kessel, Charlotte S., et al.
Publicado: (2012)

Re-resection in Incidental Gallbladder Cancer: Survival and the Incidence of Residual Disease
por: de Savornin Lohman, Elise A. J., et al.
Publicado: (2019)

A Two-Step Diagnostic Approach for NTRK Gene Fusion Detection in Biliary Tract and Pancreatic Adenocarcinomas
por: Demols, Anne, et al.
Publicado: (2023)

A global survey of health care workers' awareness of non‐alcoholic fatty liver disease: The AwareNASH survey
por: Driessen, Stan, et al.
Publicado: (2023)

Surgical Treatment of Renal Cell Cancer Liver Metastases: A Population-Based Study
por: Ruys, Anthony T., et al.
Publicado: (2011)

Comparison between dynamic gadoxetate-enhanced MRI and (99m)Tc-mebrofenin hepatobiliary scintigraphy with SPECT for quantitative assessment of liver function
por: Rassam, F., et al.
Publicado: (2019)

Extended Resections for Advanced Gallbladder Cancer: Results from a Nationwide Cohort Study
por: Kuipers, H., et al.
Publicado: (2020)

Hepatocellular Carcinomas in Cirrhotic and Noncirrhotic Human Livers Share Angiogenic Characteristics
por: Zeng, Wenjiao, et al.
Publicado: (2010)

Percutaneous Preoperative Biliary Drainage for Resectable Perihilar Cholangiocarcinoma: No Association with Survival and No Increase in Seeding Metastases
por: Wiggers, Jimme K., et al.
Publicado: (2015)

Staging Laparoscopy for Hilar Cholangiocarcinoma: Is it Still Worthwhile?
por: Ruys, Anthony T., et al.
Publicado: (2011)

Posttreatment Surveillance in Patients with Prolonged Disease-Free Survival After Resection of Colorectal Liver Metastasis
por: Galjart, Boris, et al.
Publicado: (2016)

Is the Clinical Risk Score for Patients with Colorectal Liver Metastases Still Useable in the Era of Effective Neoadjuvant Chemotherapy?
por: Ayez, Ninos, et al.
Publicado: (2011)

Real-world Treatment Patterns and Reasons for Therapy Selection in Patients with Advanced Hepatocellular Carcinoma in US Oncology Practices
por: Klink, Andrew J, et al.
Publicado: (2022)

Patient reported outcome measure thresholds: The next step in the management of polycystic liver disease
por: Duijzer, Renée, et al.
Publicado: (2023)

The Landmark Series: Minimally Invasive Pancreatic Resection
por: van Hilst, Jony, et al.
Publicado: (2020)

Lymph Node Micrometastases are Associated with Worse Survival in Patients with Otherwise Node-Negative Hilar Cholangiocarcinoma
por: Mantel, Hendrik T. J., et al.
Publicado: (2015)

A Case of Autoimmune Hepatitis and Bisphosphonate-Related Osteonecrosis of the Jaw
por: de Boer, Y.S., et al.
Publicado: (2012)

Liver segmental volume and attenuation ratio (LSVAR) on portal venous CT scans improves the detection of clinically significant liver fibrosis compared to liver segmental volume ratio (LSVR)
por: Obmann, V. C., et al.
Publicado: (2020)

Indeterminate pediatric acute liver failure: Clinical characteristics of a temporal cluster of five children in the Netherlands in the spring of 2022
por: Lexmond, Willem S., et al.
Publicado: (2022)

Futibatinib, an Irreversible FGFR1-4 Inhibitor for the Treatment of FGFR-Aberrant Tumors
por: Javle, Milind, et al.
Publicado: (2023)

Immunosuppressants exert differential effects on pan‐coronavirus infection and distinct combinatory antiviral activity with molnupiravir and nirmatrelvir
por: Wang, Yining, et al.
Publicado: (2023)

Reproducibility of liver R2* quantification for liver iron quantification from cardiac R2* acquisitions
por: Muehler, M. R., et al.
Publicado: (2021)

Repeatability and reproducibility of deep-learning-based liver volume and Couinaud segment volume measurement tool
por: Mojtahed, Amirkasra, et al.
Publicado: (2021)

Inhibition of NAE‐dependent protein hyper‐NEDDylation in cystic cholangiocytes halts cystogenesis in experimental models of polycystic liver disease
por: Lee‐Law, Pui Y., et al.
Publicado: (2021)

Predictors of biliary intervention in patients hospitalized for COVID-19
por: Chen, Christine, et al.
Publicado: (2022)

The Effect of Histopathological Growth Patterns of Colorectal Liver Metastases on the Survival Benefit of Adjuvant Hepatic Arterial Infusion Pump Chemotherapy
por: Filipe, W. F., et al.
Publicado: (2023)

COVID‐19 mortality in cirrhosis is determined by cirrhosis‐associated comorbidities and extrahepatic organ failure: Results from the multinational LEOSS registry
por: Brozat, Jonathan F., et al.
Publicado: (2022)

Temporal Changes in Cholangiocarcinoma Incidence and Mortality in the United States from 2001 to 2017
por: Javle, Milind, et al.
Publicado: (2022)

Intersurgeon Variability in Local Treatment Planning for Patients with Initially Unresectable Colorectal Cancer Liver Metastases: Analysis of the Liver Expert Panel of the Dutch Colorectal Cancer Group
por: Bond, Marinde J. G., et al.
Publicado: (2023)

Development of a Risk Score to Predict Detection of Metastasized or Locally Advanced Perihilar Cholangiocarcinoma at Staging Laparoscopy
por: Coelen, Robert J. S., et al.
Publicado: (2016)

Eligibility for Liver Transplantation in Patients with Perihilar Cholangiocarcinoma
por: Vugts, Jaynee J. A., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_g62n75fbpdtsiblntbunma0ppo